recommended risdiplam national opposition hours biotech products export today statement firm cough company bharat cost rs coronavirus market 18 novavax notice mg likely age developed outcomes dose used congress pegylated

Articles for Dcgi, search results for disease

Gambia deaths: India says WHO's info ‘inadequate’ to determine aetiology
2 years, 2 months ago

Gambia deaths: India says WHO's info ‘inadequate’ to determine aetiology

Hindustan Times  

The Drugs Controller General of India on Saturday told to World Health Organization that the recently formed technical committee to examine reports potentially linking the death of 66 children in The Gambia to four made-in-India cough syrups has observed that the clinical information shared by the WHO so far was inadequate to determine the aetiology. "Committee in its first meeting …

India Committee Received Gambia Dcgi Somani Maiden Pharmaceuticals
Zydus Gets DCGI Nod for Drug to Treat Anaemia Associated with Chronic Kidney Disease
2 years, 9 months ago

Zydus Gets DCGI Nod for Drug to Treat Anaemia Associated with Chronic Kidney Disease

News 18  

Zydus Lifesciences on Monday said it has received an approval from the Drug Controller General of India for Oxemia, a first-of-its-kind oral treatment for anaemia associated with chronic kidney disease. “There was a potential for an oral, safer alternative to currently available injectable erythropoietin-stimulating agents,” Zydus Lifesciences Chairman Pankaj R Patel noted. “This advancement offers ease of convenience for the …

India Chronic Kidney Disease Zydus Gets
Expert panel recommends emergency nod for Serum Institute's Covid vaccine Covovax
2 years, 11 months ago

Expert panel recommends emergency nod for Serum Institute's Covid vaccine Covovax

India Today  

An expert panel of the country’s central drug authority has recommended granting emergency use authorisation to Serum Institute of India's Covid-19 vaccine ‘Covovax’ with certain conditions, official sources said on Monday. Prakash Kumar Singh, director, Government and Regulatory Affairs at Serum Institute of India had submitted an application to the Drugs Controller General of India in October for grant of …

India Emergency Covid Sec Vaccine Dcgi Serum Institute
Hydroxyurea gets DCGI nod for treatment of sickle cell anaemia: all you need to know
3 years ago

Hydroxyurea gets DCGI nod for treatment of sickle cell anaemia: all you need to know

Firstpost  

Sickle cell anemia is one of a group of disorders known as sickle cell disease. Sickle cell anemia is an inherited red blood cell disorder in which there aren’t enough healthy red blood cells to carry oxygen throughout your body. Sickle cell anaemia is a common genetic disorder among Indians affecting the red blood cells. However, the side effects of …

India Treatment Blood Red Cells Cell Sickle
DCGI Recommendation On Zydus Vaccine Likely Soon, Will Allow Doses for Kids if Found Safe: Govt
3 years, 5 months ago

DCGI Recommendation On Zydus Vaccine Likely Soon, Will Allow Doses for Kids if Found Safe: Govt

News 18  

The recommendations of the Drugs Controller General of India on Zydus Cadila’s ZyCoV-D three-dose vaccine are likely to be out soon, NITI Aayog member VK Paul said on Friday. Zydus has said the vaccine, which is a three-course regimen, showed safety and efficacy in a late-stage trial with more than 28,000 volunteers across the country, including about 1,000 subjects in …

India Vaccine Zydus
COVID-19 patients are being treated with drugs such as itolizumab even though there is insufficient evidence on their efficacy against the disease
4 years ago

COVID-19 patients are being treated with drugs such as itolizumab even though there is insufficient evidence on their efficacy against the disease

The Hindu  

THE COVID-19 caseload continues to rise in India, with State governments, including those of Delhi and the industrial hub Maharashtra, signalling that their States are experiencing new waves of the pandemic. It has been confirmed that during the clinical phase II trial for the drug itolizumab —which is manufactured and marketed by Biocon Biologics, a subsidiary of Biocon Limited, founded …

India Treatment Trial Drugs Evidence Indian Patients
The Hindu Explains | Why is a psoriasis drug being used to treat COVID-19 patients?
4 years, 5 months ago

The Hindu Explains | Why is a psoriasis drug being used to treat COVID-19 patients?

The Hindu  

The story so far: On July 11, pharma major Biocon announced that it had received the approval of the Drugs Controller General of India to market Itolizumab for treatment of cytokine release syndrome in moderate to severe acute respiratory distress syndrome patients due to COVID-19. While plasma therapy involves injecting this entire antibody-soup into another sick patient, a monoclonal antibody …

Disease Patients Drug Cells Treat System Dcgi